Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	SCRT2 ZNF586 ZNF680 SCRT1 ZNF484 ZNF789 OVOL3 FEZF2 ZNF569 ZNF268 ESR1 ESR2 ZNF780B ZBTB22 ZNF813 ZNF571 ZNF226 ZNF112 ZNF519 ZNF467 PRDM5 ZNF850 ZBTB1 ZNF840P ZNF441 ZNF563 OVOL2 ZGPAT ZNF16 ZNF20 ZNF836 ZNF713 OVOL1 SALL2 ZNF32 ZNF37A ZNF517 ZNF780A RBAK ZNF790 ZNF483 ZNF347 ZNF74 ZNF470 ZNF580 ZNF221 ZNF83 ZNF723 ZNF565 ZNF160 HDAC2 ZNF44	7.92e-30	1459	111	52	GO:0000977
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	SCRT2 ZNF586 ZNF680 SCRT1 ZNF484 ZNF789 OVOL3 FEZF2 ZNF569 ZNF268 ESR1 ESR2 ZNF780B ZBTB22 ZNF813 ZNF571 ZNF226 ZNF112 ZNF519 ZNF467 PRDM5 ZNF850 ZBTB1 ZNF840P ZNF441 ZNF563 OVOL2 ZGPAT ZNF16 ZNF20 ZNF836 ZNF713 OVOL1 SALL2 ZNF32 ZNF37A ZNF517 ZNF780A RBAK ZNF790 ZNF483 ZNF347 ZNF74 ZNF470 ZNF580 ZNF221 ZNF83 ZNF723 ZNF565 ZNF160 ZNF44	1.91e-29	1412	111	51	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	SCRT2 ZNF586 ZNF680 SCRT1 ZNF484 ZNF789 OVOL3 FEZF2 ZNF569 ZNF268 ESR1 ESR2 ZNF780B ZBTB22 ZNF813 ZNF571 ZNF226 ZNF112 ZNF519 ZNF467 PRDM5 ZNF850 ZBTB1 ZNF840P OVOL2 ZGPAT ZNF16 ZNF836 ZNF713 OVOL1 SALL2 ZNF32 ZNF37A ZNF780A RBAK ZNF790 ZNF483 ZNF347 ZNF74 ZNF470 ZNF580 ZNF221 ZNF83 ZNF723 ZNF565 ZNF160 HDAC2	1.06e-27	1244	111	47	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	SCRT2 ZNF586 ZNF680 SCRT1 ZNF484 ZNF789 OVOL3 FEZF2 ZNF569 ZNF268 ESR1 ESR2 ZNF780B ZBTB22 ZNF813 ZNF571 ZNF226 ZNF112 ZNF519 ZNF467 PRDM5 ZNF850 ZBTB1 ZNF840P OVOL2 ZGPAT ZNF16 ZNF836 ZNF713 OVOL1 SALL2 ZNF32 ZNF37A ZNF780A RBAK ZNF790 ZNF483 ZNF347 ZNF74 ZNF470 ZNF580 ZNF221 ZNF83 ZNF723 ZNF565 ZNF160 HDAC2	2.71e-27	1271	111	47	GO:0000987
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	ZNF484 FEZF2 ZNF268 ESR1 ESR2 ZNF780B ZNF226 ZNF112 ZNF519 ZNF467 ZNF850 ZNF840P OVOL2 ZNF836 SALL2 ZNF780A ZNF580	1.28e-08	560	111	17	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	ZNF484 FEZF2 ZNF268 ESR1 ESR2 ZNF780B ZNF226 ZNF112 ZNF519 ZNF467 ZNF850 ZNF840P OVOL2 ZNF836 SALL2 ZNF780A ZNF580	1.50e-08	566	111	17	GO:0001216
GeneOntologyMolecularFunction	nuclear estrogen receptor activity	ESR1 ESR2	1.82e-04	4	111	2	GO:0030284
GeneOntologyMolecularFunction	DNA-binding transcription repressor activity, RNA polymerase II-specific	SCRT2 SCRT1 FEZF2 PRDM5 ZBTB1 OVOL2 ZGPAT OVOL1	4.21e-04	320	111	8	GO:0001227
GeneOntologyMolecularFunction	DNA-binding transcription repressor activity	SCRT2 SCRT1 FEZF2 PRDM5 ZBTB1 OVOL2 ZGPAT OVOL1	4.76e-04	326	111	8	GO:0001217
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	ZNF484 FEZF2 ZNF268 ESR1 ESR2 ZNF780B RNF40 ZNF226 ZNF112 ZNF467 PRDM5 ZNF850 ZNF840P OVOL2 ZNF836 SALL2 FIZ1 RNF20 SMARCC1 ZNF580 HDAC2	1.08e-05	1390	109	21	GO:0045944
GeneOntologyCellularComponent	HULC complex	RNF40 RNF20	1.64e-04	4	110	2	GO:0033503
Domain	Znf_C2H2/integrase_DNA-bd	SCRT2 ZNF586 ZNF680 SCRT1 ZNF484 ZNF789 OVOL3 FEZF2 ZNF569 ZNF268 ZNF780B ZBTB22 ZNF813 ZNF571 ZNF214 ZNF226 ZNF112 ZNF519 ZNF467 PRDM5 ZNF850 ZBTB1 ZNF441 ZNF563 OVOL2 ZNF16 ZNF20 ZNF836 ZNF713 OVOL1 SALL2 GTF3A ZNF32 ZNF37A ZNF517 ZNF780A ZNF45 RBAK FIZ1 ZNF790 ZNF483 ZNF347 ZNF74 ZNF470 ZNF580 ZNF221 ZNF83 ZNF565 ZNF160 ZNF44	1.27e-43	694	104	50	IPR013087
Domain	zf-C2H2	SCRT2 ZNF586 ZNF680 SCRT1 ZNF484 ZNF789 FEZF2 ZNF569 ZNF268 ZNF780B ZBTB22 ZNF813 ZNF571 ZNF214 ZNF226 ZNF112 ZNF519 ZNF467 PRDM5 ZNF850 ZBTB1 ZNF441 ZNF563 OVOL2 ZNF16 ZNF20 ZNF836 ZNF713 OVOL1 SALL2 GTF3A ZNF32 ZNF37A ZNF517 ZNF780A ZNF45 RBAK FIZ1 ZNF790 ZNF483 ZNF347 ZNF74 ZNF470 ZNF580 ZNF221 ZNF83 ZNF565 ZNF160 ZNF44	2.99e-42	693	104	49	PF00096
Domain	Znf_C2H2-like	SCRT2 ZNF586 ZNF680 SCRT1 ZNF484 ZNF789 OVOL3 FEZF2 ZNF569 ZNF268 ZNF780B ZBTB22 ZNF813 ZNF571 ZNF214 ZNF226 ZNF112 ZNF519 ZNF467 PRDM5 ZNF850 ZBTB1 ZNF441 ZNF563 OVOL2 ZNF16 ZNF20 ZNF836 ZNF713 OVOL1 SALL2 GTF3A ZNF32 ZNF37A ZNF517 ZNF780A ZNF45 RBAK FIZ1 ZNF790 ZNF483 ZNF347 RBM6 ZNF74 ZNF470 ZNF580 ZNF221 ZNF83 ZNF565 ZNF160 ZNF44	4.99e-42	796	104	51	IPR015880
Domain	ZnF_C2H2	SCRT2 ZNF586 ZNF680 SCRT1 ZNF484 ZNF789 OVOL3 FEZF2 ZNF569 ZNF268 ZNF780B ZBTB22 ZNF813 ZNF571 ZNF214 ZNF226 ZNF112 ZNF519 ZNF467 PRDM5 ZNF850 ZBTB1 ZNF441 ZNF563 OVOL2 ZNF16 ZNF20 ZNF836 ZNF713 OVOL1 SALL2 GTF3A ZNF32 ZNF37A ZNF517 ZNF780A ZNF45 RBAK FIZ1 ZNF790 ZNF483 ZNF347 RBM6 ZNF74 ZNF470 ZNF580 ZNF221 ZNF83 ZNF565 ZNF160 ZNF44	1.06e-41	808	104	51	SM00355
Domain	-	SCRT2 ZNF586 ZNF680 SCRT1 ZNF484 ZNF789 FEZF2 ZNF569 ZNF268 ZNF780B ZBTB22 ZNF813 ZNF571 ZNF214 ZNF226 ZNF112 ZNF519 ZNF467 PRDM5 ZNF850 ZBTB1 ZNF441 ZNF563 OVOL2 ZNF16 ZNF20 ZNF836 OVOL1 SALL2 GTF3A ZNF32 ZNF37A ZNF517 ZNF780A ZNF45 RBAK FIZ1 ZNF790 ZNF483 ZNF347 ZNF74 ZNF470 ZNF580 ZNF221 ZNF83 ZNF565 ZNF160 ZNF44	2.75e-41	679	104	48	3.30.160.60
Domain	ZINC_FINGER_C2H2_2	SCRT2 ZNF586 ZNF680 SCRT1 ZNF484 ZNF789 OVOL3 FEZF2 ZNF569 ZNF268 ZNF780B ZBTB22 ZNF813 ZNF571 ZNF214 ZNF226 ZNF112 ZNF519 ZNF467 PRDM5 ZNF850 ZBTB1 ZNF441 ZNF563 OVOL2 ZNF16 ZNF20 ZNF836 ZNF713 OVOL1 SALL2 GTF3A ZNF32 ZNF37A ZNF517 ZNF780A ZNF45 RBAK FIZ1 ZNF790 ZNF483 ZNF347 ZNF74 ZNF470 ZNF580 ZNF221 ZNF83 ZNF565 ZNF160 ZNF44	3.02e-41	775	104	50	PS50157
Domain	ZINC_FINGER_C2H2_1	SCRT2 ZNF586 ZNF680 SCRT1 ZNF484 ZNF789 OVOL3 FEZF2 ZNF569 ZNF268 ZNF780B ZBTB22 ZNF813 ZNF571 ZNF214 ZNF226 ZNF112 ZNF519 ZNF467 PRDM5 ZNF850 ZBTB1 ZNF441 ZNF563 OVOL2 ZNF16 ZNF20 ZNF836 ZNF713 OVOL1 SALL2 GTF3A ZNF32 ZNF37A ZNF517 ZNF780A ZNF45 RBAK FIZ1 ZNF790 ZNF483 ZNF347 ZNF74 ZNF470 ZNF580 ZNF221 ZNF83 ZNF565 ZNF160 ZNF44	3.43e-41	777	104	50	PS00028
Domain	Znf_C2H2	SCRT2 ZNF586 ZNF680 SCRT1 ZNF484 ZNF789 OVOL3 FEZF2 ZNF569 ZNF268 ZNF780B ZBTB22 ZNF813 ZNF571 ZNF214 ZNF226 ZNF112 ZNF519 ZNF467 PRDM5 ZNF850 ZBTB1 ZNF441 ZNF563 OVOL2 ZNF16 ZNF20 ZNF836 ZNF713 OVOL1 SALL2 GTF3A ZNF32 ZNF37A ZNF517 ZNF780A ZNF45 RBAK FIZ1 ZNF790 ZNF483 ZNF347 ZNF74 ZNF470 ZNF580 ZNF221 ZNF83 ZNF565 ZNF160 ZNF44	1.96e-40	805	104	50	IPR007087
Domain	KRAB	ZNF586 ZNF680 ZNF484 ZNF789 ZNF569 ZNF268 ZNF780B ZNF813 ZNF571 ZNF214 ZNF226 ZNF112 ZNF519 ZNF850 ZNF441 ZNF563 ZNF20 ZNF836 ZNF713 ZNF37A ZNF517 ZNF780A ZNF45 RBAK ZNF790 ZNF483 ZNF347 ZNF74 ZNF470 ZNF221 ZNF565 ZNF160 ZNF44	1.97e-31	358	104	33	PS50805
Domain	KRAB	ZNF586 ZNF680 ZNF484 ZNF789 ZNF569 ZNF268 ZNF780B ZNF813 ZNF571 ZNF214 ZNF226 ZNF112 ZNF519 ZNF850 ZNF441 ZNF563 ZNF20 ZNF836 ZNF713 ZNF37A ZNF517 ZNF780A ZNF45 RBAK ZNF790 ZNF483 ZNF347 ZNF74 ZNF470 ZNF221 ZNF565 ZNF160 ZNF44	1.97e-31	358	104	33	PF01352
Domain	KRAB	ZNF586 ZNF680 ZNF484 ZNF789 ZNF569 ZNF268 ZNF780B ZNF813 ZNF571 ZNF214 ZNF226 ZNF112 ZNF519 ZNF850 ZNF441 ZNF563 ZNF20 ZNF836 ZNF713 ZNF37A ZNF517 ZNF780A ZNF45 RBAK ZNF790 ZNF483 ZNF347 ZNF74 ZNF470 ZNF221 ZNF565 ZNF160 ZNF44	5.37e-31	369	104	33	SM00349
Domain	KRAB	ZNF586 ZNF680 ZNF484 ZNF789 ZNF569 ZNF268 ZNF780B ZNF813 ZNF571 ZNF214 ZNF226 ZNF112 ZNF519 ZNF850 ZNF441 ZNF563 ZNF20 ZNF836 ZNF713 ZNF37A ZNF517 ZNF780A ZNF45 RBAK ZNF790 ZNF483 ZNF347 ZNF74 ZNF470 ZNF221 ZNF565 ZNF160 ZNF44	5.88e-31	370	104	33	IPR001909
Domain	zf-C2H2_6	SCRT2 ZNF586 ZNF680 SCRT1 ZNF789 FEZF2 ZNF569 ZNF780B ZNF813 ZNF571 ZNF467 PRDM5 ZNF850 ZNF16 ZNF20 ZNF836 SALL2 ZNF780A ZNF790 ZNF483 ZNF160 ZNF44	2.45e-18	314	104	22	PF13912
Domain	ZnF_C2HC	FAM90A14 FAM90A27P SF1 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A10	6.90e-10	55	104	8	SM00343
Domain	Znf_CCHC	FAM90A14 FAM90A27P SF1 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A10	6.90e-10	55	104	8	IPR001878
Domain	ZnF_C3H1	DHX57 ZC3H10 ZGPAT UNK PARP12	6.88e-06	48	104	5	SM00356
Domain	zf-CCCH	DHX57 ZC3H10 ZGPAT UNK PARP12	7.63e-06	49	104	5	PF00642
Domain	Znf_CCCH	DHX57 ZC3H10 ZGPAT UNK PARP12	1.76e-05	58	104	5	IPR000571
Domain	ZF_C3H1	DHX57 ZC3H10 ZGPAT UNK PARP12	1.76e-05	58	104	5	PS50103
Domain	TF_Ovo-like	OVOL2 OVOL1	3.07e-05	2	104	2	IPR027755
Domain	-	DHX57 ZC3H10 ZGPAT UNK	7.11e-05	40	104	4	4.10.1000.10
Domain	Laminin_N	LAMA2 NTN4 USH2A	8.91e-05	16	104	3	IPR008211
Domain	LAMININ_NTER	LAMA2 NTN4 USH2A	8.91e-05	16	104	3	PS51117
Domain	Laminin_N	LAMA2 NTN4 USH2A	8.91e-05	16	104	3	PF00055
Domain	LamNT	LAMA2 NTN4 USH2A	8.91e-05	16	104	3	SM00136
Domain	Oest_rcpt/oest-rel_rcp	ESR1 ESR2	3.04e-04	5	104	2	IPR024178
Domain	EGF_LAM_2	LAMA2 NTN4 USH2A	6.10e-04	30	104	3	PS50027
Domain	EGF_LAM_1	LAMA2 NTN4 USH2A	6.10e-04	30	104	3	PS01248
Domain	Laminin_EGF	LAMA2 NTN4 USH2A	9.64e-04	35	104	3	PF00053
Domain	EGF_Lam	LAMA2 NTN4 USH2A	9.64e-04	35	104	3	SM00180
Domain	Laminin_EGF	LAMA2 NTN4 USH2A	1.23e-03	38	104	3	IPR002049
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	ZNF586 ZNF680 ZNF484 ZNF569 ZNF268 ESR1 ESR2 ZNF571 ZNF214 ZNF226 ZNF112 ZNF519 ZNF441 ZNF563 ZNF20 ZNF713 ZNF37A ZNF517 ZNF45 ZNF790 ZNF483 ZNF347 SMARCC1 ZNF74 ZNF470 ZNF221 ZNF565 ZNF160 HDAC2	9.16e-13	1387	67	29	M734
Pathway	REACTOME_GENERIC_TRANSCRIPTION_PATHWAY	ZNF569 ZNF268 ESR1 ESR2 ZNF780B ZNF226 ZNF112 ZNF519 ZNF850 ZNF563 ZNF836 ZNF780A ZNF45 ZNF483 ZNF347 SMARCC1 ZNF221 ZNF160 ZNF44	1.58e-09	768	67	19	MM14851
Pathway	REACTOME_GENE_EXPRESSION_TRANSCRIPTION	ZNF569 ZNF268 ESR1 ESR2 ZNF780B ZNF226 ZNF112 ZNF519 ZNF850 POLR3A ZNF563 ZNF836 GTF3A ZNF780A ZNF45 ZNF483 ZNF347 SMARCC1 ZNF221 ZNF160 ZNF44	4.96e-09	1022	67	21	MM15436
Pathway	REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS	FN1 LAMA2 ITGAV NTN4 DMD	8.55e-06	59	67	5	M27218
Pathway	WP_SULFATASE_AND_AROMATASE_PATHWAY	ESR1 ESR2 SLCO4C1	3.60e-05	14	67	3	M48085
Pathway	KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY	ESR1 ESR2	4.60e-04	7	67	2	M47805
Pubmed	Characterization and evolution of the novel gene family FAM90A in primates originated by multiple duplication and rearrangement events.	FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10	1.11e-21	25	113	11	17684299
Pubmed	Analysis of the multi-copy gene family FAM90A as a copy number variant in different ethnic backgrounds.	FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A16 FAM90A10	9.62e-20	23	113	10	18602769
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZNF569 ESR1 ESR2 ZBTB22 PRDM5 SF1 OVOL2 ZC3H10 ZGPAT ZNF836 OVOL1 GTF3A PDLIM1 RBAK FIZ1 ZNF790 ZNF347 SMARCC1 UNK ZNF160 PARP12	1.78e-13	808	113	21	20412781
Pubmed	Acetylation-Mimic Mutation of TRIM28-Lys304 to Gln Attenuates the Interaction with KRAB-Zinc-Finger Proteins and Affects Gene Expression in Leukemic K562 Cells.	ZNF680 ZNF789 ZNF569 ZNF813 ZNF441 ZNF563 ZNF20 ZNF780A ZNF45 ZNF74 ZNF160 ZNF44	8.55e-13	181	113	12	37372979
Pubmed	Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network.	FAM90A14 FN1 FAM90A27P FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A10	7.02e-12	164	113	11	22967998
Pubmed	Multiple genes encoding zinc finger domains are expressed in human T cells.	ZNF16 ZNF20 ZNF32 ZNF37A ZNF45 ZNF44	7.09e-10	31	113	6	2288909
Pubmed	Molecular phylogeny of OVOL genes illustrates a conserved C2H2 zinc finger domain coupled by hypervariable unstructured regions.	OVOL3 OVOL2 OVOL1	3.34e-08	3	113	3	22737237
Pubmed	SUPT6H controls estrogen receptor activity and cellular differentiation by multiple epigenomic mechanisms.	ESR1 RNF40 RNF20	1.33e-07	4	113	3	24441044
Pubmed	The DNA sequence and biology of human chromosome 19.	OVOL3 ZNF780B ZNF226 ZNF112 FAM90A27P ZNF780A ZNF45 ZNF470 ZNF221	4.05e-07	284	113	9	15057824
Pubmed	Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR.	ZNF569 ZNF850 ZNF836 ZNF347 ZNF160	5.63e-07	49	113	5	9630514
Pubmed	Estrogen-dependent uterine secretion of osteopontin activates blastocyst adhesion competence.	FN1 ESR1 ESR2 ITGAV	8.92e-07	23	113	4	23152823
Pubmed	Characterization of the mid-foregut transcriptome identifies genes regulated during lung bud induction.	ZNF850 ZBTB1 ZNF836 ZNF347 ZNF160	1.57e-06	60	113	5	18023262
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	ESR1 ZBTB22 ZNF226 ZNF467 ZBTB1 SF1 OVOL1 SALL2 GTF3A ZNF780A SMARCC1 ZNF580	3.55e-06	709	113	12	22988430
Pubmed	Integrin repertoire on myogenic cells changes during the course of primary myogenesis in the mouse.	FN1 LAMA2 ITGAV	5.41e-06	11	113	3	15739233
Pubmed	Ovol1 regulates meiotic pachytene progression during spermatogenesis by repressing Id2 expression.	OVOL3 OVOL2 OVOL1	7.19e-06	12	113	3	15716349
Pubmed	Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1.	RNF40 RNF20 SMARCC1 HDAC2	8.82e-06	40	113	4	34585037
Pubmed	Involvement of SF-1 in neurogenesis and neuronal migration in the developing neocortex.	ESR1 ESR2 SF1	9.33e-06	13	113	3	26067405
Pubmed	Reduced expression of oestrogen receptor-β is associated with tumour invasion and metastasis in oestrogen receptor-α-negative human papillary thyroid carcinoma.	ESR1 ESR2	1.05e-05	2	113	2	29655286
Pubmed	CpG methylation of the ERalpha and ERbeta genes in breast cancer.	ESR1 ESR2	1.05e-05	2	113	2	15254780
Pubmed	Chronic estradiol treatment reduces platelet responses and protects mice from thromboembolism through the hematopoietic estrogen receptor α.	ESR1 ESR2	1.05e-05	2	113	2	22776819
Pubmed	Alleles and haplotypes of the estrogen receptor alpha gene are associated with an increased risk of spontaneous abortion.	ESR1 ESR2	1.05e-05	2	113	2	19200973
Pubmed	Estrogen receptor alpha and beta polymorphisms are associated with semen quality.	ESR1 ESR2	1.05e-05	2	113	2	19959825
Pubmed	Role of estrogen receptor α and β in preserving hippocampal function during aging.	ESR1 ESR2	1.05e-05	2	113	2	23392694
Pubmed	Effects of ERβ and ERα on OVX-induced changes in adiposity and insulin resistance.	ESR1 ESR2	1.05e-05	2	113	2	32053493
Pubmed	Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.	ESR1 ESR2	1.05e-05	2	113	2	11826769
Pubmed	Extended tropism of an adenoviral vector does not circumvent the maturation-dependent transducibility of mouse skeletal muscle.	LAMA2 DMD	1.05e-05	2	113	2	10753064
Pubmed	Ablation of estrogen receptor alpha or beta eliminates sex differences in mechanical pain threshold in normal and inflamed mice.	ESR1 ESR2	1.05e-05	2	113	2	19285805
Pubmed	Expression of estrogen receptors in the pelvic floor of pre- and post-menopausal women presenting pelvic organ prolapse.	ESR1 ESR2	1.05e-05	2	113	2	22038234
Pubmed	Differential association of juvenile and adult systemic lupus erythematosus with genetic variants of oestrogen receptors alpha and beta.	ESR1 ESR2	1.05e-05	2	113	2	20961965
Pubmed	Polymorphisms in the estrogen receptor beta gene but not estrogen receptor alpha gene affect the risk of developing endometriosis in a Japanese population.	ESR1 ESR2	1.05e-05	2	113	2	15193490
Pubmed	Tamoxifen induces hypercoagulation and alterations in ERα and ERβ dependent on breast cancer sub-phenotype ex vivo.	ESR1 ESR2	1.05e-05	2	113	2	33159119
Pubmed	Phytoestrogens induce differential estrogen receptor alpha- or Beta-mediated responses in transfected breast cancer cells.	ESR1 ESR2	1.05e-05	2	113	2	16118406
Pubmed	Expression of aromatase and estrogen receptors in lumbar motoneurons of mice.	ESR1 ESR2	1.05e-05	2	113	2	28501695
Pubmed	Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta.	ESR1 ESR2	1.05e-05	2	113	2	20372779
Pubmed	Human permanent tooth sizes are associated with genes encoding oestrogen receptors.	ESR1 ESR2	1.05e-05	2	113	2	32985343
Pubmed	Deficiency in mammalian histone H2B ubiquitin ligase Bre1 (Rnf20/Rnf40) leads to replication stress and chromosomal instability.	RNF40 RNF20	1.05e-05	2	113	2	22354749
Pubmed	The distribution of cells containing estrogen receptor-alpha (ERalpha) and ERbeta messenger ribonucleic acid in the preoptic area and hypothalamus of the sheep: comparison of males and females.	ESR1 ESR2	1.05e-05	2	113	2	10919284
Pubmed	Estrogen Receptor Expression in Pancreatic Adenocarcinoma: Time to Reconsider Evidence.	ESR1 ESR2	1.05e-05	2	113	2	34860807
Pubmed	Receptor null mice reveal contrasting roles for estrogen receptor alpha and beta in reproductive tissues.	ESR1 ESR2	1.05e-05	2	113	2	11162937
Pubmed	Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy?	ESR1 ESR2	1.05e-05	2	113	2	16735942
Pubmed	Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours.	ESR1 ESR2	1.05e-05	2	113	2	16880783
Pubmed	Endogenous estradiol and its association with estrogen receptor gene polymorphisms.	ESR1 ESR2	1.05e-05	2	113	2	16949384
Pubmed	Estrogen receptor genotype and risk of cognitive impairment in elders: findings from the Health ABC study.	ESR1 ESR2	1.05e-05	2	113	2	17889406
Pubmed	Sex steroid hormone polymorphisms, high-density lipoprotein cholesterol, and apolipoprotein A-1 from the Study of Women's Health Across the Nation (SWAN).	ESR1 ESR2	1.05e-05	2	113	2	16949390
Pubmed	The association of bone mineral density with estrogen receptor gene polymorphisms.	ESR1 ESR2	1.05e-05	2	113	2	16949392
Pubmed	Sex differences in exercise-induced physiological myocardial hypertrophy are modulated by oestrogen receptor beta.	ESR1 ESR2	1.05e-05	2	113	2	24654233
Pubmed	Sex-Specific Involvement of Estrogen Receptors in Behavioral Responses to Stress and Psychomotor Activation.	ESR1 ESR2	1.05e-05	2	113	2	30863326
Pubmed	Estrogen receptor α- (ERα), but not ERβ-signaling, is crucially involved in mechanostimulation of bone fracture healing by whole-body vibration.	ESR1 ESR2	1.05e-05	2	113	2	29367057
Pubmed	Immunohistochemical expression of estrogen receptors alpha and beta in lobular neoplasia.	ESR1 ESR2	1.05e-05	2	113	2	17924141
Pubmed	Differential expression of estrogen receptor α and β isoforms in multiple and solitary leiomyomas.	ESR1 ESR2	1.05e-05	2	113	2	26529545
Pubmed	Roles of estrogen receptor α and β in the regulation of proliferation in endometrial carcinoma.	ESR1 ESR2	1.05e-05	2	113	2	32853964
Pubmed	Localization of estrogen and androgen receptors in male reproductive tissues of mice and rats.	ESR1 ESR2	1.05e-05	2	113	2	15278948
Pubmed	Pregnancy and oestrogen regulate sinoatrial node calcium homeostasis and accelerate pacemaking.	ESR1 ESR2	1.05e-05	2	113	2	29800268
Pubmed	The differential fate of mesonephric tubular-derived efferent ductules in estrogen receptor-alpha knockout versus wild-type female mice.	ESR1 ESR2	1.05e-05	2	113	2	11014235
Pubmed	17Beta-estradiol regulation of the mRNA expression of T-type calcium channel subunits: role of estrogen receptor alpha and estrogen receptor beta.	ESR1 ESR2	1.05e-05	2	113	2	19003958
Pubmed	Differential expression patterns and clinical significance of estrogen receptor-α and β in papillary thyroid carcinoma.	ESR1 ESR2	1.05e-05	2	113	2	24884830
Pubmed	Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio.	ESR1 ESR2	1.05e-05	2	113	2	18955141
Pubmed	Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy.	ESR1 ESR2	1.05e-05	2	113	2	15374829
Pubmed	Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.	ESR1 ESR2	1.05e-05	2	113	2	19382890
Pubmed	Variants in estrogen receptor alpha gene are associated with phenotypical expression of obsessive-compulsive disorder.	ESR1 ESR2	1.05e-05	2	113	2	20850223
Pubmed	The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.	ESR1 ESR2	1.05e-05	2	113	2	24859835
Pubmed	Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells.	ESR1 ESR2	1.05e-05	2	113	2	24192230
Pubmed	Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice.	ESR1 ESR2	1.05e-05	2	113	2	11557741
Pubmed	Transgenic models of metabolic bone disease: impact of estrogen receptor deficiency on skeletal metabolism.	ESR1 ESR2	1.05e-05	2	113	2	12952206
Pubmed	Determination of the isoflavone composition and estrogenic activity of commercial dietary supplements based on soy or red clover.	ESR1 ESR2	1.05e-05	2	113	2	26023053
Pubmed	Both estrogen receptor-alpha and -beta are required for sexual differentiation of the anteroventral periventricular area in mice.	ESR1 ESR2	1.05e-05	2	113	2	16239299
Pubmed	Estrogen receptor beta-deficient female mice develop a bladder phenotype resembling human interstitial cystitis.	ESR1 ESR2	1.05e-05	2	113	2	17522255
Pubmed	Ratio of Circulating Estrogen Receptors Beta and Alpha (ERβ/ERα) Indicates Endoscopic Activity in Patients with Crohn's Disease.	ESR1 ESR2	1.05e-05	2	113	2	28823012
Pubmed	Estrogen receptor polymorphisms and the vascular effects of hormone therapy.	ESR1 ESR2	1.05e-05	2	113	2	21106950
Pubmed	Untangling the human estrogen receptor gene structure.	ESR1 ESR2	1.05e-05	2	113	2	12111450
Pubmed	Generation and reproductive phenotypes of mice lacking estrogen receptor beta.	ESR1 ESR2	1.05e-05	2	113	2	9861029
Pubmed	Molecular analysis of the estrogen receptor alpha gene in men with coronary artery disease: association with disease status.	ESR1 ESR2	1.05e-05	2	113	2	12691862
Pubmed	Association of promoter methylation of ERα and ERβ with sporadic breast cancer--a study from North India.	ESR1 ESR2	1.05e-05	2	113	2	24833090
Pubmed	Long-Term Neonatal Estrogen Exposure Causes Irreversible Inhibition of LH Pulses by Suppressing Arcuate Kisspeptin Expression via Estrogen Receptors α and β in Female Rodents.	ESR1 ESR2	1.05e-05	2	113	2	28368450
Pubmed	Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury.	ESR1 ESR2	1.05e-05	2	113	2	15698835
Pubmed	The oxidative stress in breast tumors of postmenopausal women is ERα/ERβ ratio dependent.	ESR1 ESR2	1.05e-05	2	113	2	23499841
Pubmed	The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17beta-estradiol.	ESR1 ESR2	1.05e-05	2	113	2	22615145
Pubmed	Novel effects of estradiol and estrogen receptor alpha and beta on cognitive function.	ESR1 ESR2	1.05e-05	2	113	2	11074057
Pubmed	Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease.	ESR1 ESR2	1.05e-05	2	113	2	21586296
Pubmed	Effects of low-magnitude high-frequency vibration on osteoblasts are dependent on estrogen receptor α signaling and cytoskeletal remodeling.	ESR1 ESR2	1.05e-05	2	113	2	30093109
Pubmed	Estrogen receptors in breast carcinogenesis and endocrine therapy.	ESR1 ESR2	1.05e-05	2	113	2	25433206
Pubmed	Estrogen receptor null mice: what have we learned and where will they lead us?	ESR1 ESR2	1.05e-05	2	113	2	10368776
Pubmed	Association of estrogen receptor gene polymorphisms with susceptibility to adolescent idiopathic scoliosis.	ESR1 ESR2	1.05e-05	2	113	2	16648749
Pubmed	Differential regulation of proteasome-dependent estrogen receptor alpha and beta turnover in cultured human uterine artery endothelial cells.	ESR1 ESR2	1.05e-05	2	113	2	12727987
Pubmed	Evidence for functional estrogen receptors alpha and beta in human adipose cells: regional specificities and regulation by estrogens.	ESR1 ESR2	1.05e-05	2	113	2	14761887
Pubmed	Expression of estrogen receptor alpha and beta in breast cancers of pre- and post-menopausal women.	ESR1 ESR2	1.05e-05	2	113	2	18752050
Pubmed	Estrogen receptors alpha and beta in choroid plexus epithelial cells in Alzheimer's disease.	ESR1 ESR2	1.05e-05	2	113	2	15082146
Pubmed	Significance of immunohistochemical expression of estrogen receptors alpha and beta in squamous cell carcinoma of the esophagus.	ESR1 ESR2	1.05e-05	2	113	2	17634528
Pubmed	Gonadotropin-positive pituitary tumors accompanied by ovarian tumors in aging female ERbeta-/- mice.	ESR1 ESR2	1.05e-05	2	113	2	20308571
Pubmed	Association of polymorphisms in the estrogen receptors alpha, and beta (ESR1, ESR2) with the occurrence of male infertility and semen parameters.	ESR1 ESR2	1.05e-05	2	113	2	20599614
Pubmed	Sex-dependent association of blood pressure with oestrogen receptor genes ERalpha and ERbeta.	ESR1 ESR2	1.05e-05	2	113	2	15167447
Pubmed	Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells.	ESR1 ESR2	1.05e-05	2	113	2	12242035
Pubmed	Peritoneal fluid macrophages in endometriosis: correlation between the expression of estrogen receptors and inflammation.	ESR1 ESR2	1.05e-05	2	113	2	17548071
Pubmed	[Prognostic value of estrogen receptors--ERalpha and ERbeta, in patients with lung cancer].	ESR1 ESR2	1.05e-05	2	113	2	21972702
Pubmed	The role of allelic variation in estrogen receptor genes and major depression in the Nurses Health Study.	ESR1 ESR2	1.05e-05	2	113	2	26169989
Pubmed	A novel shift in estrogen receptor expression occurs as estradiol suppresses inflammation-associated colon tumor formation.	ESR1 ESR2	1.05e-05	2	113	2	23702470
Pubmed	Impaired estrogen signaling underlies regulatory T cell loss-of-function in the chronically inflamed intestine.	ESR1 ESR2	1.05e-05	2	113	2	32632016
Pubmed	Identification of ligands with bicyclic scaffolds provides insights into mechanisms of estrogen receptor subtype selectivity.	ESR1 ESR2	1.05e-05	2	113	2	16648639
Pubmed	Association between polymorphisms in genes encoding estrogen receptors (ESR1 and ESR2) and excreted bisphenol A levels after orthodontic bracket bonding: a preliminary study.	ESR1 ESR2	1.05e-05	2	113	2	29961922
Pubmed	Analysis of dystrophin in fast- and slow-twitch skeletal muscles from mdx and dy2J mice at different ages.	LAMA2 DMD	1.05e-05	2	113	2	2183046
Interaction	TRIM28 interactions	LRWD1 ZNF680 FN1 ZNF484 ZNF789 ZNF569 ZNF268 ESR1 ZNF813 ZNF226 ZNF112 ZBTB1 ZNF441 POLR3A ZNF563 ZNF20 ZNF713 ZNF37A ZNF517 ZNF780A ZNF45 RBAK ZNF483 RNF20 SMARCC1 ZNF74 ZNF160 ZNF44	2.10e-10	1474	98	28	int:TRIM28
Interaction	ZNF652 interactions	ESR1 ESR2 PRDM5 RBAK	2.45e-05	35	98	4	int:ZNF652
Interaction	ZNF467 interactions	ZNF813 DHX57 ZNF467 ZC3H10 ZNF16 RBAK ZNF483	2.72e-05	179	98	7	int:ZNF467
Interaction	MSL2 interactions	ESR1 ESR2 RNF40 RNF20	3.07e-05	37	98	4	int:MSL2
Interaction	MSL1 interactions	ESR1 ESR2 RNF40 RNF20 SMARCC1	3.23e-05	75	98	5	int:MSL1
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	ZNF586 OVOL3 ZNF569 ZNF818P ZNF780B ZNF813 ZNF571 ZNF226 ZNF112 FAM90A27P ZNF850 ZNF836 ZNF780A ZNF45 FIZ1 ZNF790 ZNF347 ZNF470 ZNF580 ZNF221 ZNF83 ZNF565 ZNF160	1.74e-14	1192	113	23	chr19q13
Cytoband	8p23.1	FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10	1.83e-13	154	113	11	8p23.1
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10	1.75e-11	234	113	11	chr8p23
Cytoband	19q13.12	OVOL3 ZNF569 ZNF571 ZNF850 ZNF790 ZNF565	2.66e-08	72	113	6	19q13.12
Cytoband	19q13.42	ZNF818P ZNF813 FAM90A27P FIZ1 ZNF347 ZNF580 ZNF160	2.85e-08	125	113	7	19q13.42
Cytoband	19q13.2	ZNF780B ZNF226 ZNF112 ZNF780A ZNF45 ZNF221	3.49e-06	164	113	6	19q13.2
Cytoband	19p13.2	ZNF441 ZNF563 ZNF20 ZNF44	2.54e-03	229	113	4	19p13.2
Cytoband	Ensembl 112 genes in cytogenetic band chr9q31	SVEP1 ZNF483 RNF20	4.79e-03	137	113	3	chr9q31
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	SCRT2 ZNF586 ZNF680 SCRT1 ZNF484 ZNF789 FEZF2 ZNF569 ZNF268 ZNF780B ZBTB22 ZNF813 ZNF571 ZNF214 ZNF226 ZNF112 ZNF519 ZNF467 PRDM5 ZNF850 ZBTB1 ZNF441 ZNF563 OVOL2 ZNF16 ZNF20 ZNF836 ZNF713 OVOL1 SALL2 GTF3A ZNF32 ZNF37A ZNF517 ZNF780A ZNF45 RBAK FIZ1 ZNF790 ZNF483 ZNF347 ZNF74 ZNF470 ZNF580 ZNF221 ZNF83 ZNF565 ZNF160 ZNF44	6.22e-44	718	93	49	28
GeneFamily	Zinc fingers C2H2-type\|SNAG transcriptional repressors	SCRT2 SCRT1 OVOL1	1.54e-05	10	93	3	1259
GeneFamily	Zinc fingers CCCH-type	ZC3H10 ZGPAT UNK PARP12	3.04e-05	35	93	4	73
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 KIF26B PDLIM7 LAMA2 SVEP1 DMD	5.19e-06	191	102	6	107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 KIF26B PDLIM7 LAMA2 SVEP1 DMD	5.19e-06	191	102	6	bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 ESR2 LAMA2 SVEP1 NAV2 DMD	5.68e-06	194	102	6	81713e0409e8be695ba5dfdc67a997b33435dd9e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 ESR2 LAMA2 SVEP1 NAV2 DMD	5.68e-06	194	102	6	627cffe2d448e74fc5df92e74e5b922a73304137
ToppCell	TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3\|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9	RBM12B TECTA PRDM5 ZNF37A RBAK	1.49e-05	135	102	5	ac20133d4a36f48338b45bffb13e842cb66f83ad
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM7 LAMA2 SVEP1 ZNF221 DMD	2.98e-05	156	102	5	d5207dbfbcfb885557ea1378dfe6a56d7102e94a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM7 LAMA2 SVEP1 ZNF221 DMD	2.98e-05	156	102	5	363f1b661048d25895e2b8681c82894c957b29c0
ToppCell	severe-CD4+_T_naive\|World / disease stage, cell group and cell class	PRDM5 ZGPAT ZNF836 ZNF713 ZNF470	3.08e-05	157	102	5	ccf9abe0b59e9ea728cec4bba1872ffe14c7385c
ToppCell	severe-CD4+_T_naive\|severe / disease stage, cell group and cell class	PRDM5 ZGPAT ZNF713 ZNF470 ZNF565	4.13e-05	167	102	5	02a8215fca59c357c1cdaa5738849eacf98c0bcc
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 LAMA2 ZNF519 SVEP1 PDLIM1	4.25e-05	168	102	5	d19a115365c5415e51c039718d7669de788fcf33
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM7 LAMA2 SVEP1 NAV2 DMD	4.50e-05	170	102	5	fa753cc8fbd04e63c9a303da4dc17ee2ce907f92
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM7 LAMA2 SVEP1 NAV2 DMD	4.50e-05	170	102	5	03044e1436443b28dd39d5ef4fdb25c18e3a7546
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 LAMA2 SVEP1 TEX30 DMD	5.30e-05	176	102	5	9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 LAMA2 SVEP1 TEX30 DMD	5.30e-05	176	102	5	3f8274a7ab67f9f8a8923193763a5543cfe4defa
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FEZF2 ASIC2 ATP8B1 TECTA SLCO4C1	6.06e-05	181	102	5	08f44323bf71b6004a921bbc969c954c75feeb66
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 LAMA2 SVEP1 NAV2 DMD	6.22e-05	182	102	5	44764676ed3f51ba171ce63f669390392fa50a43
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 LAMA2 SVEP1 NAV2 DMD	6.22e-05	182	102	5	d82f59a3f930a840dde27dc6ab024f227a26d446
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 LAMA2 SVEP1 NAV2 DMD	6.55e-05	184	102	5	c5436a8e45f471b8d1301abbe9c7879204537f52
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 LAMA2 SVEP1 NAV2 DMD	6.55e-05	184	102	5	e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCell	CD8+_Memory_T_cell-FLU-0\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	PDLIM7 ZNF563 PDLIM1 ZNF580 ZNF221	6.89e-05	186	102	5	b5edd4ec462c7cd87f567b8b6f86259ddbbf096d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SUSD4 ASIC2 NAV2 ZNF83 ZNF44	7.07e-05	187	102	5	87b3d0478693d4c54ff06b74e5903036b9c1ee6a
ToppCell	COVID-19-Fibroblasts-Airway_smooth_muscle\|COVID-19 / group, cell type (main and fine annotations)	FN1 KIF26B PDLIM7 LAMA2 DMD	7.07e-05	187	102	5	464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SUSD4 ASIC2 NAV2 ZNF83 ZNF44	7.07e-05	187	102	5	42a1267bfc27b4460b8409ada580a87c4385841c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SUSD4 ASIC2 NAV2 ZNF83 ZNF44	7.07e-05	187	102	5	64afdea159f5e67a1e5cea35ce898aae6e80aea5
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 LAMA2 SVEP1 NAV2 DMD	7.43e-05	189	102	5	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 LAMA2 SVEP1 NAV2 DMD	7.43e-05	189	102	5	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 PDLIM7 LAMA2 SVEP1 DMD	7.62e-05	190	102	5	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 LAMA2 SVEP1 NAV2 DMD	7.81e-05	191	102	5	a6c57627077fa980b7ec1d3894b5f31bfb11b738
ToppCell	(2)_Fibroblasts-(21)_Fibro-2\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	FN1 NTN4 PDLIM1 DMD PADI3	7.81e-05	191	102	5	5ee353c79055c08e8a3e2b43a0345bceb09f3890
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 LAMA2 SVEP1 NAV2 DMD	7.81e-05	191	102	5	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 LAMA2 SVEP1 NAV2 DMD	7.81e-05	191	102	5	8f6d592edc32fdb901af30501d4360512334e8c2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 LAMA2 SVEP1 NAV2 DMD	7.81e-05	191	102	5	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 LAMA2 SVEP1 NAV2 DMD	8.00e-05	192	102	5	5105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 LAMA2 SVEP1 NAV2 DMD	8.20e-05	193	102	5	09a9ab029f01234459a88e3e994fe90ef4cbb8c6
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	FN1 KIF26B PDLIM7 LAMA2 SVEP1	8.40e-05	194	102	5	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 LAMA2 SVEP1 NAV2 DMD	8.40e-05	194	102	5	c49f72441b3557e2c3a9c4239e68c0cf0652814b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 LAMA2 SVEP1 NAV2 DMD	8.40e-05	194	102	5	cf0244a29934e515446ac917d3c30672b460fb04
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 LAMA2 SVEP1 NAV2 DMD	8.40e-05	194	102	5	e03ba6caed59fa64d4d9b042593469d4a6a3dc10
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 LAMA2 SVEP1 NAV2 DMD	8.40e-05	194	102	5	ba7f971fb9a19423602da60770f23d9fead4a451
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 PDLIM7 LAMA2 SVEP1 DMD	8.61e-05	195	102	5	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCRT1 UGGT1 ATP8B1 ITGAV OVOL2	8.61e-05	195	102	5	bd8e24dd598990204998d1dd853ba7a53dc0107e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 PDLIM7 LAMA2 SVEP1 DMD	8.61e-05	195	102	5	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	FN1 KIF26B LAMA2 SVEP1 NAV2	8.61e-05	195	102	5	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 LAMA2 SVEP1 NAV2 DMD	8.61e-05	195	102	5	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 PDLIM7 LAMA2 SVEP1 DMD	8.82e-05	196	102	5	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 PDLIM7 LAMA2 SVEP1 DMD	8.82e-05	196	102	5	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 LAMA2 SVEP1 PDLIM1 DMD	8.82e-05	196	102	5	3a6c942e2907aa07b5e12dbf9019d18f7bfca507
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 LAMA2 SVEP1 PDLIM1 DMD	8.82e-05	196	102	5	bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ESR1 LAMA2 SVEP1 PDLIM1 DMD	9.03e-05	197	102	5	09946ee8dfb15a2a32da06e5b331f3277ee934f4
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 LAMA2 SVEP1 NAV2 DMD	9.03e-05	197	102	5	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 LAMA2 SVEP1 NAV2 DMD	9.03e-05	197	102	5	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FN1 LAMA2 SVEP1 NAV2 DMD	9.03e-05	197	102	5	9b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDLIM7 ESR1 LAMA2 SVEP1 DMD	9.03e-05	197	102	5	80e153790cef37b743e22a7370ff5b3a6abf147d
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FN1 KIF26B LAMA2 SVEP1 NAV2	9.25e-05	198	102	5	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	FN1 KIF26B LAMA2 SVEP1 NAV2	9.25e-05	198	102	5	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	critical-Epithelial-FOXN4+\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	GALNT3 OVOL2 TEX30 SMARCC1 SDHA	9.25e-05	198	102	5	6b160b3d6a2c1b1641c2c7dcec1a7ef38411fec9
ToppCell	(02)_MMP9/10+\|World / shred by cell type by condition	FN1 ASIC2 PDLIM7 ITGAV NAV2	9.47e-05	199	102	5	3f78eddeaa67d3b767aa38de765632166b09a4f0
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	FN1 LAMA2 SVEP1 NAV2 DMD	9.47e-05	199	102	5	9503646ff1ad248181146ce767e9d12e882ec3bd
Drug	8-2 fluorotelomer alcohol	ESR1 ESR2 SDHA	9.94e-06	10	101	3	ctd:C529431
Drug	5-octylphenol	ESR1 ESR2	1.95e-05	2	101	2	ctd:C113977
Drug	tetradifon	ESR1 ESR2	1.95e-05	2	101	2	ctd:C005807
Drug	etocrylene	ESR1 ESR2	1.95e-05	2	101	2	CID000243274
Drug	Raloxifene	ESR1 ESR2	1.95e-05	2	101	2	DB00481
Drug	Brn 0187733	ESR1 ESR2	1.95e-05	2	101	2	CID000160446
Drug	PHTPP	ESR1 ESR2	1.95e-05	2	101	2	CID011201035
Drug	butolame	ESR1 ESR2	1.95e-05	2	101	2	CID000197608
Drug	LY 326315	ESR1 ESR2	1.95e-05	2	101	2	CID009803972
Drug	JK 1624F2-1	ESR1 ESR2	1.95e-05	2	101	2	ctd:C113642
Drug	octocrylene	ESR1 ESR2	1.95e-05	2	101	2	ctd:C088673
Drug	O-desmethylangolensin	ESR1 ESR2	1.95e-05	2	101	2	ctd:C050052
Drug	CHEMBL397775	ESR1 ESR2	1.95e-05	2	101	2	CID010214678
Drug	Cyclohexanone, 3b	ESR1 ESR2	1.95e-05	2	101	2	CID011370317
Drug	CHEMBL234633	ESR1 ESR2	1.95e-05	2	101	2	CID010192968
Drug	SureCN14514707	ESR1 ESR2	1.95e-05	2	101	2	CID010192967
Drug	(4R)-6-(ethoxymethyl)-4-(4-hydroxyphenyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol	ESR1 ESR2	1.95e-05	2	101	2	CID011175195
Drug	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	ESR1 ESR2	1.95e-05	2	101	2	DB08020
Drug	ethyl cinnamate	ESR1 ESR2	1.95e-05	2	101	2	ctd:C451418
Drug	(4R)-4-(4-hydroxyphenyl)-6-methylol-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol	ESR1 ESR2	1.95e-05	2	101	2	CID011174414
Drug	phytoene	ESR1 ESR2	1.95e-05	2	101	2	ctd:C100185
Drug	CHEMBL48352	ESR1 ESR2	1.95e-05	2	101	2	CID011522286
Drug	bromophos	ESR1 ESR2	1.95e-05	2	101	2	ctd:C100092
Drug	SureCN14514705	ESR1 ESR2	1.95e-05	2	101	2	CID010125414
Drug	3,4-dihydroxybenzaldoxime	ESR1 ESR2	1.95e-05	2	101	2	ctd:C053286
Drug	Tamoxifen	ESR1 ESR2	1.95e-05	2	101	2	DB00675
Drug	SureCN14514737	ESR1 ESR2	1.95e-05	2	101	2	CID010149292
Drug	di-(5-methylhexyl)phthalate	ESR1 ESR2	1.95e-05	2	101	2	ctd:C042791
Drug	phytofluene	ESR1 ESR2	1.95e-05	2	101	2	ctd:C003140
Drug	1x7e	ESR1 ESR2	1.95e-05	2	101	2	CID000656953
Drug	salicylaldoxime	ESR1 ESR2	1.95e-05	2	101	2	ctd:C005704
Drug	Pyrazolo[1,5-a]pyrimidine, 12d	ESR1 ESR2	1.95e-05	2	101	2	CID016103245
Drug	Pyrazolo[1,5-a]pyrimidine, 12c	ESR1 ESR2	1.95e-05	2	101	2	CID016103238
Drug	SureCN3587271	ESR1 ESR2	1.95e-05	2	101	2	CID011208678
Drug	CNP-amino	ESR1 ESR2	1.95e-05	2	101	2	CID000033473
Drug	ERB 041	ESR1 ESR2	1.95e-05	2	101	2	ctd:C478102
Drug	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	ESR1 ESR2	1.95e-05	2	101	2	DB07933
Drug	4-(4-hydroxyphenyl)-6-methyl-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol	ESR1 ESR2	1.95e-05	2	101	2	CID010125512
Drug	2-phenylbenzofuran	ESR1 ESR2	1.95e-05	2	101	2	CID003517936
Drug	steroid C	ESR1 ESR2	1.95e-05	2	101	2	CID000454473
Drug	2z4b	ESR1 ESR2	1.95e-05	2	101	2	CID011197931
Drug	dehydroestrone	ESR1 ESR2	1.95e-05	2	101	2	CID000102225
Drug	(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	ESR1 ESR2	1.95e-05	2	101	2	DB07638
Drug	prolame	ESR1 ESR2	1.95e-05	2	101	2	CID000127441
Drug	benzohydrol	ESR1 ESR2	1.95e-05	2	101	2	ctd:C020225
Drug	parthenocissin A	ESR1 ESR2	1.95e-05	2	101	2	ctd:C549189
Drug	CHEBI:428946	ESR1 ESR2	1.95e-05	2	101	2	CID011688293
Drug	F ppt	ESR1 ESR2	1.95e-05	2	101	2	CID003035869
Drug	SureCN3118249	ESR1 ESR2	1.95e-05	2	101	2	CID011519653
Drug	SureCN4017709	ESR1 ESR2	1.95e-05	2	101	2	CID011256602
Drug	CHEBI:428959	ESR1 ESR2	1.95e-05	2	101	2	CID011638242
Drug	DNC005795	ESR1 ESR2	1.95e-05	2	101	2	CID011638264
Drug	tetrahydrodaidzein	ESR1 ESR2	1.95e-05	2	101	2	ctd:C433164
Drug	tri-(2-ethylhexyl)trimellitate	ESR1 ESR2	1.95e-05	2	101	2	ctd:C036101
Drug	2-chloro-4-phenylphenol	ESR1 ESR2	1.95e-05	2	101	2	ctd:C012257
Drug	2,2,4-trimethyl-1,3-pentanediol diisobutyrate	ESR1 ESR2	1.95e-05	2	101	2	ctd:C001508
Drug	2-(3-chloro-4-hydroxyphenyl)-2-(4-hydroxyphenyl)propane	ESR1 ESR2	1.95e-05	2	101	2	ctd:C497826
Drug	2,2-bis(3-chloro-4-hydroxyphenyl)propane	ESR1 ESR2	1.95e-05	2	101	2	ctd:C497827
Drug	1-ethyl-2-(4-hydroxyphenyl)-3H-inden-5-ol	ESR1 ESR2	1.95e-05	2	101	2	CID011615788
Drug	SureCN3593776	ESR1 ESR2	1.95e-05	2	101	2	CID009948127
Drug	SureCN14047367	ESR1 ESR2	1.95e-05	2	101	2	CID010171723
Drug	Y134 compound	ESR1 ESR2	1.95e-05	2	101	2	ctd:C518540
Drug	TS 108	ESR1 ESR2	1.95e-05	2	101	2	ctd:C482068
Drug	Estriol	ESR1 ESR2	1.95e-05	2	101	2	DB04573
Drug	Estropipate	ESR1 ESR2	1.95e-05	2	101	2	DB04574
Drug	CHEBI:428952	ESR1 ESR2	1.95e-05	2	101	2	CID011674420
Drug	6-(4-hydroxyphenyl)-6,6a,7,8,9,10,11,11a-octahydrocyclohepta[c]chromen-2-ol	ESR1 ESR2	1.95e-05	2	101	2	CID010215026
Drug	4-(2-chloro-4-(2-piperidin-1-ylethoxy)phenyl)-5-(2,6-dichloro-4-hydroxyphenyl)-2-imidazoline	ESR1 ESR2	1.95e-05	2	101	2	ctd:C496952
Drug	indenestrol	ESR1 ESR2	1.95e-05	2	101	2	ctd:C047437
Drug	[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE	ESR1 ESR2	1.95e-05	2	101	2	DB06927
Drug	LY2066948	ESR1 ESR2	1.95e-05	2	101	2	CID005327043
Drug	SERBA-2	ESR1 ESR2	1.95e-05	2	101	2	CID009925763
Drug	SureCN1360427	ESR1 ESR2	1.95e-05	2	101	2	CID011720174
Drug	16 alpha-iodoestradiol	ESR1 ESR2	1.95e-05	2	101	2	ctd:C024871
Drug	Norethynodrel [68-23-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A	FN1 PDLIM7 ESR1 ZBTB1 SVEP1 ZNF45 NAV2	2.40e-05	192	101	7	1696_UP
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A	FN1 ESR1 ZNF571 ATP8B1 ZNF16 NAV2 ZNF74	2.56e-05	194	101	7	7001_UP
Drug	YIGSR	FN1 LAMA2 ITGAV NTN4 DMD	2.70e-05	79	101	5	CID000123977
Drug	Picrotoxinin [17617-45-7]; Up 200; 13.6uM; MCF7; HT_HG-U133A	TNFRSF25 FN1 ASIC2 SVEP1 PRKD3 SALL2 ZNF74	2.92e-05	198	101	7	4842_UP
Drug	TAT-59	ESR1 ESR2 DMD	4.55e-05	16	101	3	CID003034829
Drug	2-(((3,5-dichlorophenyl)carbamoyl)oxy)-2-methyl-3-butenoic acid	ESR1 ESR2	5.83e-05	3	101	2	ctd:C101851
Drug	CHF 4056	ESR1 ESR2	5.83e-05	3	101	2	ctd:C450419
Drug	Diethylstilbestrol	ESR1 ESR2	5.83e-05	3	101	2	DB00255
Drug	AC1LGHHD	ESR1 ESR2	5.83e-05	3	101	2	CID000821427
Drug	cyanophenphos	ESR1 ESR2	5.83e-05	3	101	2	ctd:C002488
Drug	2,4,6-trichlorophenyl-4'-aminophenyl ether	ESR1 ESR2	5.83e-05	3	101	2	ctd:C067259
Drug	7alpha-methyl-17alpha-ethynylestradiol	ESR1 ESR2	5.83e-05	3	101	2	ctd:C475050
Drug	bromophos-ethyl	ESR1 ESR2	5.83e-05	3	101	2	CID000020965
Drug	dihydrobiochanin A	ESR1 ESR2	5.83e-05	3	101	2	CID000439784
Drug	Estradiol	ESR1 ESR2	5.83e-05	3	101	2	DB00783
Drug	bicyclo(3.3.1)nonane	ESR1 ESR2	5.83e-05	3	101	2	CID000136101
Drug	cedrol	ESR1 ESR2	5.83e-05	3	101	2	ctd:C078669
Drug	benzophenone-6	ESR1 ESR2	5.83e-05	3	101	2	CID000008570
Drug	dichlofenthion	ESR1 ESR2	5.83e-05	3	101	2	CID000007328
Drug	Nafoxidine	ESR1 ESR2	5.83e-05	3	101	2	ctd:D009256
Drug	LY2066948	ESR1 ESR2	5.83e-05	3	101	2	ctd:C504960
Drug	p-tert-amylphenol	ESR1 ESR2	5.83e-05	3	101	2	ctd:C019566
Drug	1-(4-nitro-2-(trifluoromethyl)phenyl)-4-(3-(trifluoromethyl)phenyl)piperazine	ESR1 ESR2	5.83e-05	3	101	2	ctd:C562246
Drug	Chromans	ESR1 ESR2	5.83e-05	3	101	2	ctd:D002839
Drug	4-hydroxybenzophenone	ESR1 ESR2	5.83e-05	3	101	2	ctd:C024292
Drug	rhapontigenin	ESR1 ESR2	5.83e-05	3	101	2	ctd:C431126
Disease	prostate carcinoma in situ (implicated_via_orthology)	ESR1 ESR2	1.05e-05	2	96	2	DOID:8634 (implicated_via_orthology)
Disease	peritonitis (implicated_via_orthology)	ESR1 ESR2	3.14e-05	3	96	2	DOID:8283 (implicated_via_orthology)
Disease	Pilomatrixoma	OVOL2 OVOL1	6.26e-05	4	96	2	C0206711
Disease	glutaminyl-peptide cyclotransferase measurement	PRKD3 OVOL1	1.04e-04	5	96	2	EFO_0802570
Disease	Muscular Dystrophy	LAMA2 DMD	2.90e-04	8	96	2	C0026850
Disease	helping behavior measurement	SCRT2 USH2A	2.90e-04	8	96	2	EFO_0008538
Disease	Prostatic Intraepithelial Neoplasias	ESR1 ESR2	5.65e-04	11	96	2	C0282612
Disease	osteoarthritis	KIF26B ZNF268 PRDM5 OVOL1 RBM6	8.08e-04	222	96	5	MONDO_0005178
Disease	thalamus volume change measurement	ASIC2 KIF26B	9.29e-04	14	96	2	EFO_0021496
Disease	andro steroid monosulfate C19H28O6S (1) measurement	ZNF789 PDLIM1	1.22e-03	16	96	2	EFO_0800305
Disease	smoking status measurement	ZNF789 ASIC2 ESR1 LAMA2 DGKZ PRDM5 DCAF5 OVOL1 NAV2 SMARCC1 USH2A	1.38e-03	1160	96	11	EFO_0006527
Disease	ischemia (implicated_via_orthology)	ITGAV SF1	1.38e-03	17	96	2	DOID:326 (implicated_via_orthology)
Disease	stem Cell Growth Factor beta measurement	ZNF563 ZNF20 ZNF44	1.90e-03	75	96	3	EFO_0008292
Disease	muscular dystrophy (implicated_via_orthology)	LAMA2 DMD	2.11e-03	21	96	2	DOID:9884 (implicated_via_orthology)
Disease	in situ carcinoma (is_marker_for)	ESR1 ESR2	2.11e-03	21	96	2	DOID:8719 (is_marker_for)
Disease	anxiety disorder (implicated_via_orthology)	ESR2 HDAC2	2.32e-03	22	96	2	DOID:2030 (implicated_via_orthology)
Disease	osteoporosis (biomarker_via_orthology)	ESR1 ESR2	2.32e-03	22	96	2	DOID:11476 (biomarker_via_orthology)
Disease	venous thromboembolism, tissue plasminogen activator measurement	DGKZ ZNF160	2.53e-03	23	96	2	EFO_0004286, EFO_0004791
Disease	Malignant neoplasm of breast	FN1 ZNF569 PDLIM7 ESR1 ESR2 LAMA2 ATP8B1 TECTA DMD PADI3	2.61e-03	1074	96	10	C0006142
Disease	waist circumference	ESR2 ZGPAT OVOL1 NAV2 DMD PADI3	2.81e-03	429	96	6	EFO_0004342
Disease	Cerebral Astrocytoma	ESR1 ESR2	2.99e-03	25	96	2	C0750935
Disease	Intracranial Astrocytoma	ESR1 ESR2	2.99e-03	25	96	2	C0750936
Disease	Pilocytic Astrocytoma	ESR1 ESR2	2.99e-03	25	96	2	C0334583
Disease	Astrocytoma	ESR1 ESR2	2.99e-03	25	96	2	C0004114
Disease	Juvenile Pilocytic Astrocytoma	ESR1 ESR2	2.99e-03	25	96	2	C0280783
Disease	Diffuse Astrocytoma	ESR1 ESR2	2.99e-03	25	96	2	C0280785
Disease	Grade I Astrocytoma	ESR1 ESR2	2.99e-03	25	96	2	C1704230
Disease	Subependymal Giant Cell Astrocytoma	ESR1 ESR2	2.99e-03	25	96	2	C0205768
Disease	Mixed oligoastrocytoma	ESR1 ESR2	2.99e-03	25	96	2	C0547065
Disease	Childhood Cerebral Astrocytoma	ESR1 ESR2	2.99e-03	25	96	2	C0338070
Disease	Gemistocytic astrocytoma	ESR1 ESR2	3.24e-03	26	96	2	C0334581
Disease	Protoplasmic astrocytoma	ESR1 ESR2	3.24e-03	26	96	2	C0334580
Disease	Fibrillary Astrocytoma	ESR1 ESR2	3.24e-03	26	96	2	C0334582

Protein segments in the cluster

Peptide	Gene	Start	Entry
RKCPKCNAAFGAHDF	RNF40	981	O75150
KCPKCNAAFGANDFH	RNF20	956	Q5VTR2
DGHCEGKNLKRNRFF	CDKL3	576	Q8IVW4
ICQSCFFSGRVAKGH	DMD	3336	P11532
RLKCKNCGAFGHTAR	FAM90A10	41	A6NDY2
FKKCCINGQIYGDHR	ATP8B1	466	O43520
CKFKGQECGHQDFTT	ASIC2	171	Q16515
FASCVDASGGLKCHR	RBM12B	201	Q8IXT5
RLKCKNCGAFGHTAR	FAM90A7	41	A6NKC0
YKCKLCGKGFAHRNV	PRDM5	376	Q9NQX1
AGFCCGVIRAHKKAI	LRWD1	381	Q9UFC0
RLKCKNCGAFGHTAR	FAM90A23	41	A8MXZ1
CEGCKAFFKRSIQGH	ESR2	166	Q92731
NGADGCVFCFGHAKL	KIF26B	536	Q2KJY2
RLKCKNCGAFGHTAR	FAM90A22	41	A8MWA6
VKCKNCGAFGHSARS	FAM90A27P	41	A6NNH2
RLKCKNCGAFGHTAR	FAM90A14	41	P0C7W9
SCEGCKAFFKRSIQG	ESR1	201	P03372
CRNLYKKDLLGHFGC	DCAF5	41	Q96JK2
EGCGLNYHKRCAFKI	PRKD3	186	O94806
VTGKKCDRCAHGYFN	LAMA2	991	P24043
RLKCKNCGAFGHTAR	FAM90A17	41	P0DV74
RHLCTFCGKGFNDTF	OVOL2	146	Q9BRP0
FCGKGFNDTFDLKRH	OVOL2	151	Q9BRP0
CFKLFQEKQKCGHGR	PADI3	496	Q9ULW8
RLKCKNCGAFGHTAR	FAM90A16	41	P0DV73
FGTKCHGCDFKIDAG	PDLIM7	396	Q9NR12
RLKCKNCGAFGHTAR	FAM90A19	41	P0DV76
CGKGFNDTFDLKRHV	OVOL1	151	O14753
QGECKFGTSCKRSHD	PARP12	186	Q9H0J9
CCGKGFHDAFDLKRH	OVOL3	126	O00110
RLKCKNCGAFGHTAR	FAM90A8	41	A6NJQ4
QGSCRKKCFDASFRG	ENPP3	51	O14638
KLLCQCLGFGSGHFR	FN1	2321	P02751
KERGEAKHCFNAFAS	GALNT3	141	Q14435
GNCKFGSKCRFKHEV	DHX57	311	Q6P158
SCFNVRFCLKADGKG	ITGAV	501	P06756
HACPRCGKGFKHSFN	FIZ1	51	Q96SL8
GHFGFKEQKRGLACC	DNAI4	506	Q5VTH9
DGKCRHCGKGFQQKF	DGKZ	181	Q13574
RLKCKNCGAFGHTAR	FAM90A20P	41	A6NIJ5
RLGCFNLTVKGHAKC	HDAC2	271	Q92769
RLKCKNCGAFGHTAR	FAM90A5P	41	A8MXJ8
NFRCLCTHEKGFGFK	PPIE	171	Q9UNP9
GRHKCRFCAKVFGSD	SALL2	371	Q9Y467
RLKCKNCGAFGHTAR	FAM90A24P	41	P0C7X0
FVCEFCGKGFHQKGN	FEZF2	361	Q8TBJ5
TCGKGFCRNFDLKKH	FEZF2	421	Q8TBJ5
CTDCGTNLKQKGHFF	PDLIM1	286	O00151
KQKFIRGFCHLCDGQ	PDHA2	81	P29803
VIGLRCDHCNFGFKF	USH2A	721	O75445
KANIGGHRSSCSFCK	RBM6	546	P78332
FGCAHCGKAFADRSN	SCRT1	276	Q9BWW7
GCAHCGKAFADRSNL	SCRT2	241	Q9NQ03
QSLKFGKGGQAHRCC	SDHA	176	P31040
GFSALLHSGKCECKE	NTN4	496	Q9HB63
RLKCKNCGAFGHTAR	FAM90A12P	41	A8MX19
RLKCKNCGAFGHTAR	FAM90A9	41	A6NNJ1
RLKCKNCGAFGHTAR	FAM90A13P	41	P0C7W8
GEIFNGLLNCKYHKC	NAV2	2236	Q8IVL1
RKKNICHHCGAFNGT	POLR3A	151	O14802
GEAAAVFCCGFRDHK	SHISAL2A	26	Q6UWV7
DFDCGKAARIQCFKG	SVEP1	3021	Q4LDE5
AKCFMDFKAGGALCH	SMARCC1	106	Q92922
RLKCKNCGAFGHTAR	FAM90A15P	41	P0C7V4
FNKGGKCFCDEKHEI	ZNF37A	96	P17032
GCYSHKKFQLCGSLA	TECTA	1721	O75443
RHECGQCGKSFSRKS	ZNF586	316	Q9NXT0
GCKECGKAFSRASHL	ZNF565	236	Q8N9K5
CGKAFRCGSHLQKHG	ZNF20	316	P17024
YKCNECGKAFRGHSN	ZNF160	341	Q9HCG1
ECKQCGKAFYHLGSF	ZNF441	281	Q8N8Z8
KLHECNNCGKAFSFK	ZNF268	526	Q14587
HFKCKECGKAFNRGS	ZNF519	431	Q8TB69
FGFEAKAGKCETHCA	SLCO4C1	561	Q6ZQN7
CNECGKKFHHRSAFN	RBAK	681	Q9NYW8
RHTGNNSFKCKECGK	ZNF723	166	P0DPD5
ARFHCQDGFKLKGAT	SUSD4	81	Q5VX71
TGEKHFVCNQCGKAF	ZNF840P	496	A6NDX5
CLEKLKHSGAFQLCG	UBR1	86	Q8IWV7
KCNVCGKAFSHGSSL	ZNF470	426	Q6ECI4
SHGFFCLRFTCKGLN	TEX30	56	Q5JUR7
CKECGKFFRRGSNLN	ZNF780A	531	O75290
FECKDCGKAFNRGSN	ZNF780B	501	Q9Y6R6
AGDFHKKIGLFCCRG	TNFRSF25	36	Q93038
KCNECGKGFNRKTHL	ZNF813	496	Q6ZN06
FECAECGKAFGRKSN	ZNF517	396	Q6ZMY9
KCNECGKAFRAHSNL	ZNF347	486	Q96SE7
RKHFCNLCGKGFYQR	ZBTB1	576	Q9Y2K1
FKCDACGKSFSRNSH	ZNF226	391	Q9NYT6
KCNICGKGFNHRSVL	ZNF112	526	Q9UJU3
CKQCGKTFHHLGSFQ	ZNF563	311	Q8TA94
CGKGFICRRDFCKHQ	ZNF221	371	Q9UK13
FKCNHCGKGFNQTLD	ZNF569	186	Q5MCW4
HECKECGKAFIRGSN	ZNF790	366	Q6PG37
ECKECGKTFLHGSEF	ZNF790	451	Q6PG37
GKHFECTECGKAFTR	ZNF484	381	Q5JVG2
CSDCGKAFTRKSGLH	ZNF484	666	Q5JVG2
CHECGKAFTQGSRFI	ZNF818P	91	Q6ZRF7
QCSECGKAFRGHSDF	ZNF16	266	P17020
PFKCNECGKAFSSHA	ZNF74	471	Q16587
KCDDCGKGFTLSAHL	ZNF483	496	Q8TF39
LFKCTQEGCGKHFAS	GTF3A	161	Q92664
ECGFCGKAFSQRTHL	ZNF713	371	Q8N859
GDCQRGAKCKFRHLQ	ZC3H10	146	Q96K80
SKGNCTKNGLHCAFA	UNK	136	Q9C0B0
TCGACGKAFKRSSHL	ZNF580	121	Q9UK33
ECKQCGKAFIRGSHL	ZNF571	531	Q7Z3V5
CGKAFNGCSSLTRHK	ZNF680	411	Q8NEM1
QCGKAFCHLGSFQRH	ZNF44	361	P15621
CGKGFCRASNFLAHR	ZNF45	561	Q02386
KCGGAGHIASDCKFQ	SF1	281	Q15637
GKCRFKENCRFSHGQ	ZGPAT	186	Q8N5A5
DGNKIFLCHCGKAFS	ZBTB22	481	O15209
RCHECGKAFVRFSGL	ZNF850	926	A8MQ14
CAKCGKGFSHSSALR	ZNF214	556	Q9UL59
CAECGKRFSQKIHLG	ZNF467	246	Q7Z7K2
GCNSFFSVHGKKTCE	UGGT1	146	Q9NYU2
YKCNECGKAFHRGSL	ZNF836	246	Q6ZNA1
ECGKAFGRFSCLNKH	ZNF836	866	Q6ZNA1
ECTHCGKSFRAKGNL	ZNF32	106	P17041
GEKHFKCNECGKLFR	ZNF83	481	P51522
CGECGKTFSFKRNLF	ZNF789	371	Q5FWF6
RLKCKNCGAFGHTAR	FAM90A18	41	P0DV75